[EN] INDOLYLMALEIMIDE DERIVATIVES AS PROTEIN KINASE C INHIBITORS<br/>[FR] DERIVES D'INDOLYLMALEIMIDE UTILISES EN TANT QU'INHIBITEURS DE PROTEINE KINASE C
申请人:NOVARTIS AG
公开号:WO2002038561A1
公开(公告)日:2002-05-16
Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.
含有取代苯基、萘基、四氢萘基、喹唑啉基、喹啉基、异喹啉基或嘧啶基残基的吲哚基马来酰亚胺衍生物具有有趣的药理学特性,例如在治疗和/或预防T细胞介导的急性或慢性炎症性疾病或疾患、自身免疫疾病、移植排斥或癌症方面。